Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,655
Using PrEP, Doing It for Ourselves
for
HIV Prevention, PrEP
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT06638892
Recruiting
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families
for
Substance Abuse, Intimate Partner Violence (IPV),
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 12 - 70+
Code: NCT06627764
Recruiting
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase 1, Phase 2, Recruiting
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma, Cancer
Location: Durham NC, Chapel Hill NC, Wilmington NC, Charlotte NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05145400
Phase 2, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Fairfax VA, Pittsburgh PA, Philadelphia PA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Durham NC, Norfolk VA, Annapolis MD, Philadelphia PA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for
Low Risk Myelodysplastic Syndromes
Location: Durham NC, Columbus OH, Cleveland OH, New York NY,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05308264
Phase 1, Phase 2, Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Location: Durham NC, New York NY, Nashville TN, Providence RI,
Sponsor: Context Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06515613
Phase 1, Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Durham NC, Fairfax VA, Philadelphia PA, Nashville TN,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06108050
Phase 1, Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
for
Prostate Cancer,
Location: Durham NC, Myrtle Beach SC, Charlottesville VA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT04729114
Phase 1, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Durham NC, Huntersville NC, Fairfax VA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Durham NC, Washington DC, Baltimore MD, Boston MA,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 3 - 39
Code: NCT05096481
Phase 2, Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Durham NC, Atlanta GA, New York NY, Birmingham AL,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05143996
Phase 1, Phase 2, Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Durham NC, Atlanta GA, Toronto, Boston MA, St Louis MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Phase 4, Recruiting
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation
Sex: All
Age: 65+
Code: NCT02802267
Phase 2, Recruiting
Optimizing Surgical Decisions in Young Adults With Breast Cancer
for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Durham NC, New York NY, New Haven CT, Boston MA
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 44
Code: NCT06275126
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy